Use of Dexamethasone May Decrease the Efficacy of Immune Checkpoint Inhibitors in Patients With Glioblastoma
PHILADELPHIA – Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline...